Dizapam

Quick links to important sections

Dizapam

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dizapam

Dizapam is a prescription-only medication whose active substance is diazepam, a synthetic compound classified primarily as a benzodiazepine derivative. Its fundamental function is to modulate and reduce excessive activity within the Central Nervous System (CNS). The Dizapam trade name distinguishes this specific preparation of diazepam, which is clinically recognized for its reliable formulation and broad availability across multiple delivery systems.


Quick Facts: Dizapam Identity

Property Description
Active Ingredient Diazepam
Form Tablet, Solution (Oral/Injectable), Rectal Gel, Nasal Spray
Pharmacological Class Benzodiazepine Derivative, CNS Depressant
Origin Synthetic (Chemically Synthesized)
Status Prescription-Only (Rx)

Classification, Forms, and General Purpose

Dizapam belongs to the established benzodiazepine drug family, recognized for its capacity to produce anxiolytic (anti-anxiety), sedative, and skeletal muscle-relaxant effects. The core mechanism of this drug class involves amplifying the action of the body's main inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), which generally helps to quiet excessive neuronal signaling.

Diazepam is a long-acting agent, providing sustained relief from neuronal hyperexcitability compared to shorter-acting alternatives. Its composition is based exclusively on the single-ingredient active compound. This medication is supplied in varied dosage forms, including standard oral tablets and solutions, as well as specialized rapid-onset formulations like injectable solutions and rectal/nasal preparations. This range allows its core therapeutic action to be applied efficiently, promoting generalized calm and reduced physical tension in situations requiring the dampening of overstimulated nerve signals.

What side effects are possible with Dizapam?

Possible Side Effects and Safety Information

As a benzodiazepine derivative and central nervous system (CNS) depressant, the safety profile of Dizapam is primarily characterized by effects related to its depressant action, as classified in official regulatory documents.

Common Adverse Reactions and Organ Systems

Common adverse reactions documented in official regulatory labeling include drowsiness, fatigue, muscle weakness, and ataxia (loss of control of body movements). Other effects reported involve various physiological systems, such as confusion, depression, and dysarthria (slurred speech) within the nervous system, as well as constipation, nausea, and changes in libido.

Serious Safety Considerations

Official labeling highlights several serious safety concerns. Respiratory depression is a known risk, and caution is indicated for very ill patients or those with limited pulmonary reserve, where there is a possibility of apnea or cardiac arrest. The co-administration of Dizapam with opioid medications carries a significant risk of profound sedation, respiratory depression, coma, and death. Furthermore, the development of physical dependence and subsequent withdrawal syndromes upon abrupt discontinuation or rapid dosage reduction is an established risk associated with continued use.

Safety Constraints and Special Populations

Due to the nature of the drug's metabolism and effects, specific constraints exist. Dizapam is generally contraindicated in patients with severe respiratory insufficiency and severe hepatic insufficiency. Older adults may be more susceptible to the drug's severe CNS effects, requiring extra caution. Paradoxical reactions—acute hyperexcited states such as anxiety or rage—have also been reported; if these occur, the regulatory text specifies that use should be discontinued. The medication may impair the mental and physical abilities required for operating machinery or driving.

Overdose and Emergency Response

Overdose Manifestations and Complications

Overdose with Dizapam is officially documented as presenting with signs of Central Nervous System (CNS) Depression, which may progress in severity. Initial manifestations often include drowsiness, confusion, and lethargy, potentially advancing to slurred speech, ataxia (loss of coordination), and hypotonia (diminished muscle tone).

In severe cases, the official labeling notes the risk of profound sedation, coma, respiratory depression, and respiratory arrest. The risk of a fatal overdose is substantially increased when Dizapam is taken in combination with other CNS depressants, such as opioids or alcohol. Additionally, overdose from parenteral (injectable) formulations carries an officially documented risk of Propylene Glycol Toxicity, potentially leading to lactic acidosis.

Seeking Immediate Medical Attention

Regulatory documentation defines overdose as a serious medical emergency that requires immediate medical attention. Individuals must contact emergency services or a Poison Control Center if an overdose is suspected, particularly when severe symptoms like trouble breathing or unresponsiveness are present.

Management of overdose is primarily symptomatic and supportive care, requiring close observation and continuous monitoring of vital signs in a hospital setting. The use of the specific benzodiazepine antagonist, flumazenil, is officially recognized but carries a documented risk of precipitating seizures in certain overdose scenarios.

Therapeutic Uses of Dizapam

Quick Facts

  • Management of anxiety disorders
  • Relief of acute alcohol withdrawal symptoms
  • Adjunct for certain seizure disorders
  • Used to help relieve skeletal muscle spasms

Dizapam is an available treatment option that is indicated for the management of anxiety disorders and for the short-term relief of anxiety symptoms.

It is also used to help provide symptomatic relief for acute alcohol withdrawal, including symptoms such as agitation, tremor, and impending or acute delirium tremens. As an adjunctive treatment, the medication may be administered to help relieve skeletal muscle spasms that occur due to reflex spasm from conditions like local pathology or trauma, and spasticity caused by upper motor neuron disorders such as cerebral palsy.

Furthermore, Dizapam may be used as an adjunct in the management of certain convulsive disorders and status epilepticus. It may also be used as a premedication to help relieve anxiety and tension in patients who are to undergo surgical or medical procedures. These applications constitute the recognized therapeutic uses for this medication.

Eligibility and Restrictions for Use

Eligibility Status: Who Must Not Use Dizapam?

The official regulatory labeling establishes clear boundaries for the use of Dizapam. It is strictly contraindicated and must not be used in patients with a known hypersensitivity to the drug, myasthenia gravis, acute narrow-angle glaucoma, severe respiratory insufficiency, or severe hepatic impairment. Patients diagnosed with sleep apnea syndrome or those in a state of shock or coma (for injectable forms) are also formally prohibited from use.

Age and Physiological Restrictions

Age-Group Eligibility: The medicine is restricted for use in pediatric patients under 6 months of age for oral forms, as safety has not been formally established by regulatory bodies. Older adults require special consideration, and a reduced initial dose is required due to increased sensitivity and risk of accumulation.

Condition-Based Limitations: Caution is necessary for patients with chronic respiratory insufficiency or mild to moderate hepatic impairment, for whom a lower dose is recommended. Dizapam is also generally not recommended for use by mothers who are breastfeeding, as the drug is known to pass into breast milk.

Comorbidity Cautions: Use is not advised as a sole treatment for patients with depression or anxiety associated with depression, and extreme caution is required for individuals with a history of alcohol or drug dependence.

What should I know about interactions with other medicines?

The interaction profile for Dizapam (diazepam) is primarily structured by two categories: pharmacodynamic reinforcement and pharmacokinetic alteration via metabolism.

Pharmacodynamic Interactions

Co-administration with Opioids carries a formal regulatory Boxed Warning due to the serious risk of profound sedation, respiratory depression, coma, and death. This combination is strictly restricted. The simultaneous ingestion of Alcohol or other Central Nervous System (CNS) depressants, including certain antipsychotics, barbiturates, or sedating antihistamines, is cautioned against as it may potentiate the CNS depressant effects of Dizapam. Additionally, some herbal remedies, such as Valerian and Passionflower, are officially documented to increase these drowsy effects.


Pharmacokinetic and Exposure Alterations

Dizapam is metabolized primarily by the hepatic enzymes CYP2C19 and CYP3A4. Interactions with enzyme inhibitors (e.g., cimetidine, fluoxetine) may decrease the rate of elimination, leading to increased systemic exposure and prolonged effects. Conversely, enzyme inducers (e.g., carbamazepine, rifampin) may increase the rate of elimination, potentially resulting in reduced systemic exposure. The oral absorption is officially noted as being delayed and decreased when the medicine is administered with a moderate fat meal. Furthermore, Grapefruit Juice is documented to increase Dizapam blood levels through enzyme inhibition. Elderly patients and individuals with the CYP2C19 Poor Metabolizer genotype are noted to have a greater risk of drug accumulation.

Mechanism of Action

Dizapam functions as a positive allosteric modulator of the gamma-aminobutyric acid type A ( GABA A) receptor complex, which is a ligand-gated chloride-selective ion channel. The drug selectively binds to an allosteric site located at the interface of the alpha and gamma subunits of the GABA A receptor.

This binding event modifies the receptor's conformation, resulting in an increased affinity for the endogenous neurotransmitter GABA. When GABA subsequently binds, the frequency of chloride channel opening is enhanced. The resulting influx of negatively charged chloride ions hyperpolarizes the postsynaptic neuronal membrane, thereby increasing the difference between the resting potential and the threshold potential. This overall enhancement of inhibitory GABA A signaling leads to a reduction in the excitability of neurons across the central nervous system, particularly within the limbic system, thalamus, and cerebral cortex.

Dosage and Administration Information

How to use Dizapam

The administration of Dizapam (diazepam) involves specific routes, dosing schedules, and duration constraints. The medicine is utilized via multiple routes, including oral (tablets and solutions), intravenous (IV), intramuscular (IM), and specialized delivery systems like rectal solution/gel and intranasal spray.

Dosing and Frequency

For general adult use in conditions such as anxiety and muscle spasm, the typical oral dosing ranges from 2 mg to 10 mg per dose, administered in two to four divided doses daily. For acute, severe episodes like status epilepticus, the injectable solution is administered intravenously, starting at 5 mg to 10 mg and may be repeated at short intervals up to a maximum total dose of 30 mg.

Administration Conditions

Oral doses can be taken with or without food; however, concurrent intake with a moderate-fat meal is known to delay and decrease the rate of absorption. The intravenous form must be administered slowly, at a rate of at least one minute per 5 mg, and it is crucial that the injectable solution not be mixed or diluted with other solutions in the syringe. Use in older adults or patients with hepatic impairment involves initiating treatment at the lowest effective dose (e.g., 2 mg to 2.5 mg) and gradually increasing only as necessary.

Duration and Discontinuation

Clinical practice involves keeping the duration of continuous treatment as short as possible, typically no more than 8 to 12 weeks, inclusive of the dose-tapering period. Treatment is tapered off gradually to mitigate the risk of withdrawal reactions, reflecting its application as a short-term, structured intervention.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dizapam


Evidence for use in Anxiety Disorders and Symptom Relief

The research exploring Dizapam was conducted to examine acute anxiety symptoms, and is primarily based on short-term, placebo-controlled Randomized Controlled Trials (RCTs) and subsequent meta-analyses that consolidate findings from multiple studies. Studies monitored outcomes related to the measurement of change in physical discomfort and physiological strain often associated with anxiety. The evidence described in these studies comprises patterns observed in the short term, typically over a period of two to four weeks. The research has a limited follow-up duration for the study of generalized anxiety symptoms.

Evidence for use in Acute Alcohol Withdrawal

The research exploring Dizapam in acute alcohol withdrawal symptoms is substantial, comprising a consistent body of acute-phase Randomized Controlled Trials (RCTs). Research examined outcomes describing episodic or acute changes, focusing on how quickly symptoms—such as tremor, agitation, and heightened symptom activity—were monitored and addressed. Findings described patterns associated with the measurement of change in withdrawal-related agitation, tremor, and hyperexcitability during the acute phase of treatment (typically le 7 days). The research is derived from highly monitored clinical settings and is limited to the acute phase.

Evidence for use in Seizure Disorders and Muscle Spasms

Research for Dizapam's adjunctive uses explored two distinct research scenarios: acute convulsive episodes and skeletal muscle spasms.

For acute convulsive episodes (like status epilepticus), studies monitored the time required for seizure activity to stop and the rate of seizure recurrence shortly thereafter. Research described a pattern of cessation over defined time intervals in acute settings. For skeletal muscle spasms, evidence includes older clinical trials and systematic reviews in populations with functional limitations. The evidence base for this indication often includes generalization from the collective findings for the benzodiazepine drug class.

Long-term Studies and Durability of Response

The majority of efficacy research for Dizapam focuses on short-term intervention. Follow-up durations were limited in most controlled anxiety studies, meaning that the research provides limited information for long-term outcomes or the durability of symptom response beyond the initial weeks of use. Long-term effects are not fully established, and research specifically highlights concerns about the potential development of tolerance and dependence associated with administration over extended periods.

Key Studies & References

  1. Clinical Practice Guideline: Management of Alcohol Withdrawal Syndrome
  2. NIH: Use of Benzodiazepines in the Elderly

Frequently Asked Questions (FAQ)

Common questions about Dizapam (FAQ)


Q: Does Dizapam treat conditions other than anxiety and muscle spasms?

Official regulatory documents state that Dizapam is formally indicated for the treatment of additional conditions beyond anxiety and muscle spasms. These uses include managing acute alcohol withdrawal symptoms and serving as an adjunct therapy for certain seizure disorders, such as status epilepticus.


Q: How quickly does Dizapam start working for anxiety?

According to the official product information, Dizapam is rapidly absorbed after being taken by mouth. The drug typically reaches its peak concentration in the bloodstream, with the average time to achieve this concentration occurring in about one to one-and-a-half hours.


Q: Are there any serious, but rare, side effects associated with Dizapam use?

Official labeling highlights serious safety concerns, including the risk of respiratory depression (slowed breathing), apnea (temporary stopping of breathing), and certain acute behavioral changes known as paradoxical reactions. The most severe risks are associated with using Dizapam alongside opioid medications.


Q: Are there any common over-the-counter (OTC) medicines that interact with Dizapam?

Official information indicates that certain nonprescription products can interact with Dizapam, primarily by increasing drowsiness or slowing down the central nervous system. Regulatory information indicates a need for caution when Dizapam is co-administered with medicines that increase drowsiness, such as sedating antihistamines. Caution is also noted for drugs that inhibit metabolism, such as cimetidine or omeprazole, as these may alter Dizapam exposure.


Q: Why is Dizapam considered to have a potential for dependence or addiction?

Regulatory documents classify Dizapam as a benzodiazepine, a class of drugs with an established potential for abuse and dependence. Continued use may result in the development of physical dependence, which can lead to significant withdrawal reactions upon abrupt discontinuation.


Q: What types of symptoms are associated with Dizapam withdrawal?

Upon abrupt discontinuation or rapid dosage reduction, official guidance indicates that a person may experience various withdrawal symptoms. These often include difficulty sleeping, increased anxiety and tension, sweating, shaking (tremor), and difficulty concentrating. In severe cases, more serious reactions like seizures have been reported.


Q: What is the official guidance on taking Dizapam before a scheduled surgery or medical procedure?

Dizapam is officially used to relieve anxiety in the period just before certain surgeries or medical procedures. For this purpose, it is often administered via an injectable form in a clinical setting. Official product information notes that patients may experience a temporary loss of memory for the details of the procedure afterward.


Q: What official information is available about the long-term cognitive effects of Dizapam?

Official labeling notes common side effects like drowsiness and confusion. Studies have found that prolonged exposure to the drug may lead to changes in brain neurochemistry and behavior. However, the available human research evidence regarding specific long-term cognitive outcomes is generally noted as limited.


Q: What should a person do if they feel Dizapam is no longer working as intended?

The development of tolerance, which means the drug’s desired effect decreases over time, is a known concern with continued use. If a person feels Dizapam is no longer working as intended, regulatory information discusses the need for the prescribing clinician to review and evaluate the desirability of continued therapy. Regulatory documents also note that reducing the dosage may be required.


Q: Is Dizapam a controlled substance in the country where it is prescribed?

Yes. In the United States, Dizapam (Valium) is classified by the Drug Enforcement Administration (DEA) as a Schedule IV controlled substance. This regulatory classification acknowledges the drug's low potential for abuse and low risk of dependence relative to other controlled substances.


Q: What are the rules regarding traveling internationally with Dizapam?

Official guidance describes the requirements for traveling internationally with controlled substances like Dizapam. For example, the product must be kept in its original container with the dispensing label, and documentation, such as proof of prescription, is noted as necessary. Additionally, controlled substances are required to be declared to customs officials upon entry.


Q: Is Dizapam thought to impact blood pressure?

Official adverse reaction reports and overdosage information list hypotension, or low blood pressure, as a possible effect of Dizapam. This effect is seen most frequently when the drug is given through the intravenous route or in cases where too much of the drug has been taken.


Q: What is the current safety classification of Dizapam during pregnancy?

Current regulatory labeling provides a risk summary rather than a simple letter category. Labeling includes a statement that the drug should be used during pregnancy only if the potential benefit justifies the risk to the fetus. Neonates exposed late in pregnancy may be at risk for withdrawal symptoms and 'floppy infant syndrome' (a temporary state of limpness and weak muscles).

How should Dizapam be stored and disposed of?

Storage and Disposal of Dizapam (Diazepam)

Dizapam must be stored under specific conditions to maintain its stability and ensure child safety, as defined by regulatory labeling.


Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20^circ to 25 C or 68^circ to 77 F)
Protection Protect from light; Do not freeze
Container Keep in its original container, tightly closed
Child Safety Keep strictly out of the reach of children and pets

Disposal Instructions

Unused or expired Dizapam should be primarily disposed of through an authorized drug take-back program. As an exception to the general rule of not flushing medications, Diazepam Rectal Gel may be flushed down the toilet if no take-back option is immediately available, due to the high risk of accidental exposure to this specific formulation. Otherwise, products should not be disposed of in wastewater or household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dizapam found in:

A-Z Index: